Berlin Institute of Health Cell Sequencing COVID-19 Solutions – Intel® Chip Chat episode 704

On this episode of Chip Chat, Dr. Roland Eils, the founding director of the BIH Digital Health Center of the Berlin Institute of Health (BIH), talks with host Allyson Klein about their advanced COVID-19 cell sequencing research and how critical technology is in delivering timely results within the medical industry. During their talk, Dr. Eils explains BIH’s process in collecting COVID-19 samples from infected patients and establishing a pipeline through molecular categorization by massive genome sequencing. This large amount of data is used to help predict infected patients’ progression and recommend medical solutions. Intel’s Select Solution architecture tailored to BIH’s workload requirements has accelerated patient research and enabled quicker medical diagnostics. The two also discuss the instrumental role of the IT industry in integrating and processing large amounts of critical medical data. Finally, Dr. Eils describe the institute’s future plans to research the after-recovery effects of COVID-19 patients with international clinical data. To learn more about the Berlin Institute of Health and their project on COVID-19 cell sequencing, visit https://www.bihealth.org/en/. Notices & Disclaimers Intel technologies may require enabled hardware, software or service activation. No product or component can be absolutely secure. Your costs and results may vary. © Intel Corporation. Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands may be claimed as the property of others.